BioAge Labs Inc. (BIOA) quarterly income statement — complete revenue, gross profit & net income history
BioAge Labs Inc. (BIOA) annual income statement — 4-year revenue, gross profit & net income history
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q1'23 |
|---|
| Sales/Revenue | 2.45M | 2.77M | 3.08M | 2.05M | 2.41M | 1.45M | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | 1.62% | 91.04% | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 63K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | 2.27% | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 2.45M | 2.71M | 3.08M | 2.05M | 2.41M | 1.45M | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | 100% | 97.73% | 100% | 100% | 100% | 100% | - | - | - | - | - | - |
| Gross Profit Growth % | 1.62% | 86.7% | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 31.78M | 28.08M | 31.5M | 25.19M | 27.18M | 17.9M | 25.36M | 24.75M | 15.27M | 12.81M | 13.6M | 11.51M |
| OpEx % of Revenue | 1296.78% | 1013.13% | 1023.42% | 1226.58% | 1126.99% | 1233.43% | - | - | - | - | - | - |
| Selling, General & Admin | 7.42M | 7.67M | 7M | 6.68M | 7.34M | 6.79M | 6.14M | 4.73M | 4.8M | 3.49M | 3.51M | 3.47M |
| SG&A % of Revenue | 302.69% | 276.84% | 227.45% | 325.27% | 304.27% | 467.82% | - | - | - | - | - | - |
| Research & Development | 24.36M | 20.41M | 24.5M | 18.51M | 19.84M | 11.11M | 19.23M | 20.02M | 10.47M | 9.32M | 10.08M | 8.04M |
| R&D % of Revenue | 994.08% | 736.29% | 795.97% | 901.31% | 822.72% | 765.61% | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -29.33M | -25.38M | -28.42M | -23.14M | -24.77M | -16.45M | -25.36M | -24.75M | -15.27M | -12.81M | -13.6M | -11.51M |
| Operating Margin % | -1196.78% | -915.4% | -923.42% | -1126.58% | -1026.99% | -1133.43% | - | - | - | - | - | - |
| Operating Income Growth % | -18.42% | -54.29% | -12.07% | 6.51% | -62.23% | -28.35% | -86.54% | - | - | - | - | - |
| EBITDA | -29.26M | -25.31M | -28.35M | -23.09M | -24.71M | -16.41M | -25.32M | -24.71M | -15.22M | -12.78M | -13.55M | -11.47M |
| EBITDA Margin % | -1193.92% | -913.13% | -921.18% | -1124.2% | -1024.59% | -1130.88% | - | - | - | - | - | - |
| EBITDA Growth % | -18.41% | -54.26% | -12% | 6.56% | -62.37% | -28.4% | -86.76% | - | - | - | - | - |
| D&A (Non-Cash Add-back) | 70K | 63K | 69K | 49K | 58K | 37K | 47K | 38K | 49K | 33K | 41K | 33K |
| EBIT | -26.1M | -22.21M | -25.85M | -20.02M | -21.36M | -12.67M | -20.81M | -23.02M | -13.14M | -11.78M | -18.4M | -10.29M |
| Net Interest Income | 3.44M | 3.23M | 2.7M | 3.01M | 3.22M | 3.46M | 3.78M | 1.65M | 1.76M | 79K | -2.18M | 442K |
| Interest Income | 3.44M | 3.27M | 2.79M | 3.16M | 3.42M | 3.71M | 4.09M | 2.04M | 2.2M | 1.3M | 379K | 1.24M |
| Interest Expense | 1K | 39K | 92K | 149K | 201K | 255K | 319K | 388K | 443K | 1.22M | 2.56M | 793K |
| Other Income/Expense | 3.24M | 3.12M | 2.48M | 2.97M | 3.21M | 3.52M | 4.23M | 1.34M | 1.69M | -179K | -7.36M | 421K |
| Pretax Income | -26.1M | -22.25M | -25.94M | -20.17M | -21.56M | -12.93M | -21.13M | -23.41M | -13.58M | -12.99M | -20.96M | -11.08M |
| Pretax Margin % | -1064.75% | -802.78% | -842.85% | -982.04% | -893.99% | -890.97% | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -26.1M | -22.25M | -25.94M | -20.17M | -21.56M | -12.93M | -21.13M | -23.41M | -13.58M | -12.99M | -20.96M | -11.08M |
| Net Margin % | -1064.75% | -802.78% | -842.85% | -982.04% | -893.99% | -890.97% | - | - | - | - | - | - |
| Net Income Growth % | -21.03% | -72.13% | -22.78% | 13.82% | -58.77% | 0.49% | -0.82% | - | - | - | - | - |
| Net Income (Continuing) | -26.1M | -22.25M | -25.94M | -20.17M | -21.56M | -12.93M | -21.13M | -23.41M | -13.58M | -12.99M | -20.96M | -11.08M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.58 | -0.52 | -0.72 | -0.56 | -0.60 | -0.36 | -0.59 | -0.68 | -0.40 | -0.38 | -0.61 | -1.48 |
| EPS Growth % | 3.33% | -44.44% | -22.03% | 17.65% | -50% | 5.26% | 3.28% | - | - | - | - | - |
| EPS (Basic) | -0.58 | -0.52 | -0.72 | -0.56 | -0.60 | -0.36 | -0.59 | -0.68 | -0.40 | -0.38 | -0.61 | -1.48 |
| Diluted Shares Outstanding | 44.84M | 42.48M | 36.11M | 35.85M | 35.85M | 35.85M | 35.85M | 34.2M | 34.17M | 34.2M | 34.2M | 7.46M |
| Basic Shares Outstanding | 44.84M | 42.48M | 36.11M | 35.85M | 35.85M | 35.85M | 35.85M | 34.2M | 34.17M | 34.2M | 34.2M | 7.46M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |